National Institutes of Health Clinical Center (CC) clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 0 with minor changes only.

1. Notable

   Spironolactone for Pulmonary Arterial Hypertension

   Primary and study completion pushed from Dec 31, 2026 to Dec 31, 2031

   National Institutes of Health Clinical Center (CC)·Phase 2· NCT01712620· Registry history of NCT01712620 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Notable

   Samples From Human Subjects to Facilitate Basic, Translational and…Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research

   Primary and study completion pushed from Aug 1, 2027 to Aug 1, 2037

   National Institutes of Health Clinical Center (CC)·Not specified·Unusual date· NCT03253705· Registry history of NCT03253705 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

3. Notable

   Fusion Guided Focal Laser Ablation of Prostate Cancer

   Primary completion pushed from Jan 21, 2027 to Jul 31, 2029

   Also in this update: Study completion pushed from Jan 21, 2027 to Jul 31, 2032

   National Institutes of Health Clinical Center (CC)·Not applicable· NCT02759744· Registry history of NCT02759744 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.